Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Marongiu, Luigi ^a   Godi, Anna ^a   Parry, John V ^a   Beddows, Simon ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Cervical cancer; Genotypes; Human papillomavirus; Integration; Methylation; Viral load

Indexed keywords

ARTICLE; CONTROLLED STUDY; CPG ISLAND; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; DNA METHYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 45; NONHUMAN; PAPILLOMAVIRUS INFECTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS DNA CELL DNA INTERACTION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS TYPING; ADULT; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 18; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

ADULT; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD; VIRUS INTEGRATION;

EID: 84902263092     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-384     Document Type: Article

References (40)

1. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007, 370:890-907. 10.1016/S0140-6736(07)61416-0, 17826171.
2. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. A review of human carcinogens--Part B: biological agents. Lancet Oncol 2009, 10:321-322. 10.1016/S1470-2045(09)70096-8, 19350698.
3. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, Clifford GM. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Canc 2012, 131:2349-2359.
4. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Canc 2006, 119:1095-1101.
5. Cuzick J, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Ho L, Terry G, Liddle S, Wright C, Lyons D, Szarewski A. Comparing the performance of six human papillomavirus tests in a screening population. Br J Canc 2013, 108:908-913.
6. Saunier M, Monnier-Benoit S, Mauny F, Dalstein V, Briolat J, Riethmuller D, Kantelip B, Schwarz E, Mougin C, Pretet JL. Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol 2008, 46:3678-3685. 10.1128/JCM.01212-08, 2576617, 18799702.
7. Cricca M, Morselli-Labate AM, Venturoli S, Ambretti S, Gentilomi GA, Gallinella G, Costa S, Musiani M, Zerbini M. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Gynecol Oncol 2007, 106:549-557. 10.1016/j.ygyno.2007.05.004, 17568661.
8. Hesselink AT, Berkhof J, Heideman DA, Bulkmans NW, van Tellingen JE, Meijer CJ, Snijders PJ. High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer. Int J Canc 2009, 124:381-386.
9. Ho CM, Chien TY, Huang SH, Lee BH, Chang SF. Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecol Oncol 2006, 102:54-60. 10.1016/j.ygyno.2005.11.035, 16386784.
10. Das D, Bhattacharjee B, Sen S, Mukhopadhyay I, Sengupta S. Association of viral load with HPV16 positive cervical cancer pathogenesis: causal relevance in isolates harboring intact viral E2 gene. Virology 2010, 402:197-202. 10.1016/j.virol.2010.03.030, 20394955.
11. Boulet GA, Benoy IH, Depuydt CE, Horvath CA, Aerts M, Hens N, Vereecken AJ, Bogers JJ. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting?. Canc Epidemiol Biomarkers Prev 2009, 18:2992-2999.
12. Briolat J, Dalstein V, Saunier M, Joseph K, Caudroy S, Pretet JL, Birembaut P, Clavel C. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN. Int J Canc 2007, 121:2198-2204.
13. Cheung JL, Lo KW, Cheung TH, Tang JW, Chan PK. Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. J Infect Dis 2006, 194:1706-1712. 10.1086/509622, 17109343.
14. Flores R, Papenfuss M, Klimecki WT, Giuliano AR. Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Canc 2006, 118:1187-1193.
15. Cheung JL, Cheung TH, Tang JW, Chan PK. Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer. J Clin Microbiol 2008, 46:1356-1362. 10.1128/JCM.01785-07, 2292946, 18272718.
16. Cheung JL, Cheung TH, Ng CW, Yu MY, Wong MC, Siu SS, Yim SF, Chan PK. Analysis of human papillomavirus type 18 load and integration status from low-grade cervical lesion to invasive cervical cancer. J Clin Microbiol 2009, 47:287-293. 10.1128/JCM.01531-08, 2643667, 19036939.
17. Chan PK, Cheung JL, Cheung TH, Lo KW, Yim SF, Siu SS, Tang JW. Profile of viral load, integration, and E2 gene disruption of HPV58 in normal cervix and cervical neoplasia. J Infect Dis 2007, 196:868-875. 10.1086/520884, 17703417.
18. Vinokurova S, Wentzensen N, Kraus I, Klaes R, Driesch C, Melsheimer P, Kisseljov F, Durst M, Schneider A, von Knebel Doeberitz M. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Canc Res 2008, 68:307-313.
19. Kulmala SM, Syrjanen SM, Gyllensten UB, Shabalova IP, Petrovichev N, Tosi P, Syrjanen KJ, Johansson BC. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 2006, 59:513-517. 10.1136/jcp.2004.024570, 1860285, 16484445.
20. Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Lie K, Barrera-Saldana HA, Wiley DJ, Bernard HU. Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol 2004, 78:12762-12772. 10.1128/JVI.78.23.12762-12772.2004, 525027, 15542628.
21. Sun C, Reimers LL, Burk RD. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer. Gynecol Oncol 2011, 121:59-63. 10.1016/j.ygyno.2011.01.013, 3062667, 21306759.
22. Mirabello L, Schiffman M, Ghosh A, Rodriguez AC, Vasiljevic N, Wentzensen N, Herrero R, Hildesheim A, Wacholder S, Scibior-Bentkowska D, Burk RD, Lorincz AT. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int J Canc 2013, 132:1412-1422.
23. Snellenberg S, Schutze DM, Claassen-Kramer D, Meijer CJ, Snijders PJ, Steenbergen RD. Methylation status of the E2 binding sites of HPV16 in cervical lesions determined with the Luminex(R) xMAP system. Virology 2012, 422:357-365. 10.1016/j.virol.2011.11.006, 22137333.
24. Brandsma JL, Sun Y, Lizardi PM, Tuck DP, Zelterman D, Haines GK, Martel M, Harigopal M, Schofield K, Neapolitano M. Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 2009, 389:100-107. 10.1016/j.virol.2009.03.029, 2918277, 19443004.
25. Fernandez AF, Rosales C, Lopez-Nieva P, Grana O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambio A, Fraga MF, Pino I, Javierre B, Carmona FJ, Acquadro F, Steenbergen RD, Snijders PJ, Meijer CJ, Pineau P, Dejean A, Lloveras B, Capella G, Quer J, Buti M, Esteban JI, Allende H, Rodriguez-Frias F, Castellsague X, Minarovits J, Ponce J, Capello D. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 2009, 19:438-451. 2661803, 19208682.
26. Mirabello L, Sun C, Ghosh A, Rodriguez AC, Schiffman M, Wentzensen N, Hildesheim A, Herrero R, Wacholder S, Lorincz A, Burk RD. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. J Natl Canc Inst 2012, 104:556-565.
27. Xi LF, Jiang M, Shen Z, Hulbert A, Zhou XH, Lin YY, Kiviat NB, Koutsky LA. Inverse association between methylation of human papillomavirus type 16 DNA and risk of cervical intraepithelial neoplasia grades 2 or 3. PLoS One 2011, 6:e23897. 10.1371/journal.pone.0023897, 3161083, 21887341.
28. Badal V, Chuang LS, Tan EH, Badal S, Villa LL, Wheeler CM, Li BF, Bernard HU. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 2003, 77:6227-6234. 10.1128/JVI.77.11.6227-6234.2003, 154984, 12743279.
29. Wentzensen N, Sun C, Ghosh A, Kinney W, Mirabello L, Wacholder S, Shaber R, LaMere B, Clarke M, Lorincz AT, Castle PE, Schiffman M, Burk RD. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. J Natl Canc Inst 2012, 104:1738-1749.
30. Turan T, Kalantari M, Calleja-Macias IE, Cubie HA, Cuschieri K, Villa LL, Skomedal H, Barrera-Saldana HA, Bernard HU. Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression?. Virology 2006, 349:175-183. 10.1016/j.virol.2005.12.033, 16472835.
31. Clarke MA, Wentzensen N, Mirabello L, Ghosh A, Wacholder S, Harari A, Lorincz A, Schiffman M, Burk RD. Human papillomavirus DNA methylation as a potential biomarker for cervical cancer. Canc Epidemiol Biomarkers Prev 2012, 21:2125-2137.
32. Das Ghosh D, Bhattacharjee B, Sen S, Premi L, Mukhopadhyay I, Chowdhury RR, Roy S, Sengupta S. Some novel insights on HPV16 related cervical cancer pathogenesis based on analyses of LCR methylation, viral load, E7 and E2/E4 expressions. PLoS One 2012, 7:e44678. 10.1371/journal.pone.0044678, 3435323, 22970286.
33. Howell-Jones R, Bailey A, Beddows S, Sargent A, de Silva N, Wilson G, Anton J, Nichols T, Soldan K, Kitchener HC. Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England. Br J Canc 2010, 103:209-216.
34. Rajeevan MS, Swan DC, Duncan K, Lee DR, Limor JR, Unger ER. Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing. J Virol Meth 2006, 138:170-176.
35. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM. Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 2006, 44:1755-1762. 10.1128/JCM.44.5.1755-1762.2006, 1479176, 16672403.
36. Bryant D, Tristram A, Liloglou T, Hibbitts S, Fiander A, Powell N. Quantitative measurement of Human Papillomavirus type 16 L1/L2 DNA methylation correlates with cervical disease grade. J Clin Virol 2014, 59:24-29. 10.1016/j.jcv.2013.10.029, 24268385.
37. Kalantari M, Osann K, Calleja-Macias IE, Kim S, Yan B, Jordan S, Chase DM, Tewari KS, Bernard HU. Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia. Virology 2014, 448:314-321. 4051423, 24314662.
38. Cheung JL, Cheung TH, Yu MY, Chan PK. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome. Gynecol Oncol 2013, 131:374-379. 10.1016/j.ygyno.2013.08.026, 24012799.
39. Eklund C, Forslund O, Wallin KL, Dillner J. Global improvement in genotyping of Human Papillomavirus DNA: The 2011 HPV LabNet International Proficiency Study. J Clin Microbiol 2014, 52:449-459. 10.1128/JCM.02453-13, 24478473.
40. van Alewijk D, Kleter B, Vent M, Delroisse JM, de Koning M, van Doorn LJ, Quint W, Colau B. A human papilloma virus testing algorithm comprising a combination of the L1 broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specific genotyping PCR assay. J Clin Microbiol 2013, 51:1171-1178. 10.1128/JCM.02831-12, 3666791, 23363835.